Jump to content

Darodipine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by John of Reading (talk | contribs) at 11:11, 1 July 2020 (Typo/general fixes, replaced: a effect → an effect). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Darodipine
Names
IUPAC name
4-(2,1,3-Benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1/C19H21N3O5/c1-5-25-18(23)14-10(3)20-11(4)15(19(24)26-6-2)16(14)12-8-7-9-13-17(12)22-27-21-13/h7-9,16,20H,5-6H2,1-4H3
    Key: QERUYFVNIOLCHV-UHFFFAOYAW
  • O=C(OCC)\C3=C(\N\C(=C(\C(=O)OCC)C3c1cccc2nonc12)C)C
Properties
C19H21N3O5
Molar mass 371.393 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Darodipine is an experimental calcium channel blocker that based on animal models may reduce neuronal cytoskeletal alterations during aging and in neurodegenerative disorders. Studies performed on rats have shown darodipine to have an effect on brain serotonergic systems. Darodipine increased the 5-HIAA/5-HT ratio within various parts of the brain.[1] Darodipine has also been shown to impair memory and learning processes on mice.[2]

See also

References

  1. ^ Gaggi, Renato (June–July 1995). "Effects of isradipine and darodipine on serotonergic system of the rat brain". Pharmacology, Biochemistry and Behavior. 51 (2): 183–187.
  2. ^ Lamberti, C. (Dec 1994). "Effects of the calcium-channel blockers darodipine and nimodipine on amnesia induced by three different hypoxic methods". Pharmacological Research. 30: 359.